https://www.marketscreener.com/quote/stock/GALECTIN-THERAPEUTICS-INC-10274771/news/Galectin-Therapeutics-Announces-Positive-Top-Line-Results-from-a-Phase-1b-Clinical-Trial-Extension-35826251/?utm_source=telegram&utm_medium=social&utm_campaign=share